Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

BACKGROUND: Patients with impaired liver function (ILF) were excluded from clinical trials that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of NOACs in atri...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Tseng, Hsiao‐Jung, Wen, Ming‐Shien, Chang, Shang‐Hung
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://ncbi.nlm.nih.gov/pubmed/30371232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009263
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky